azelastine hydrochloride and fluticasone propionate

DRUG3 trials

Sponsors

Meda Pharmaceuticals, Teva Pharmaceuticals USA, St. Paul's Sinus Centre

Conditions

Allergic RhinitisSeasonal Allergic Rhinitis

Phase 3

Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)

CompletedNCT01915823

Meda PharmaceuticalsSeasonal Allergic Rhinitis

Start: 2013-07-31Updated: 2015-06-29

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Teva Pharmaceuticals USASeasonal Allergic Rhinitis

Start: 2014-08-31Target: 1535Updated: 2014-09-25

Phase 4

Allergic Rhinitis Combination Pharmacotherapy Efficacy Study

WithdrawnNCT04601324

St. Paul's Sinus CentreAllergic Rhinitis

Start: 2020-12-15End: 2021-07-01Updated: 2023-10-31